Innovators relieved, generics companies frustrated as government drops generic substitution plans for England
This article was originally published in SRA
The new UK coalition government has dropped plans to introduce automatic generic substitution in England because of uncertainty over whether the government's proposals would have provided real benefit to the National Health Service, says the Department of Health1,2. Some parts of the pharmaceutical industry appeared to be relieved, but generics producers were frustrated.
You may also be interested in...
Meindert Boysen, head of NICE’s Centre For Health Technology Evaluation, shares advice for companies aiming to get their medicine to patients. His golden rules: engage in early advice and be more realistic about pricing.
In an exclusive interview with the Pink Sheet, senior NICE director Meindert Boysen reveals the best advice he ever received and how companies whose products are under review can improve their chances of success.
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.